Bombay High Court Demands Action Report on Illegal Pathology Laboratories in Maharashtra
The Nagpur bench of the Bombay High Court issued a significant directive on Tuesday, compelling the Maharashtra government to produce a comprehensive report detailing actions taken against illegal pathology laboratories operating throughout the state. This judicial intervention underscores mounting concerns regarding patient safety and the effectiveness of regulatory enforcement mechanisms in the healthcare sector.
Court's Directive and Petition Details
Hearing a criminal Public Interest Litigation (PIL) filed by Yavatmal-based social activist Digambar Pajgade, a division bench comprising Justices Anil Kilor and Raj Wakode orally instructed the state to disclose all steps implemented thus far. The court explicitly demanded a thorough account of previous enforcement measures, questioning, "What action was taken against such illegal laboratories?" This inquiry seeks to clarify the extent of compliance and oversight within the diagnostic industry.
The petition alleges that thousands of blood testing laboratories are being operated unlawfully by technicians holding only a Diploma in Medical Laboratory Technology (DMLT) or Certificate in Medical Laboratory Technology (CMLT). Current regulations mandate that such facilities must be run exclusively by qualified medical professionals, including MBBS doctors and specialists in pathology, microbiology, or biochemistry. The plea argues that this widespread practice of unauthorized operation poses a direct and severe risk to public health, potentially compromising diagnostic accuracy and patient care standards.
State's Response and Regulatory Framework
During earlier hearings, Suvarna Kharat, Joint Secretary in the state's Medical Education and Drugs Department, informed the court that the regulation of these establishments falls under the Clinical Establishments (Registration and Regulation) Act, 2010, which is a central government enactment. The state submitted that while hospitals are governed under the Bombay Nursing Homes Registration Act, the oversight of pathology laboratories is aligned with this central legislation.
However, the court remained unsatisfied with this general explanation and sought a more concrete account of on-the-ground enforcement. The bench directed the state to place on record specific details, including the number of inspections conducted, violations identified, and concrete actions taken against unauthorized laboratories. This directive highlights the judiciary's focus on tangible outcomes rather than mere regulatory frameworks.
Broader Concerns and Legal Representation
The petition has brought to light broader concerns regarding regulatory fragmentation between state and central frameworks, as well as significant gaps in implementation that could adversely affect diagnostic services. The issue raises critical questions about how overlapping jurisdictions and enforcement lapses might undermine patient safety and healthcare quality.
During the proceedings, Digambar Pajgade argued the matter in person, while NS Rao represented the state government. Deputy Solicitor General Kartik Shukul appeared for the central government, indicating the multi-level governmental involvement in this regulatory challenge.
Key Issues Highlighted
- Regulatory Gaps: The bench has questioned the state on enforcement and regulatory actions taken against illegal laboratories.
- Petition Allegations: The plea claims laboratories are run illegally by DMLT and CMLT technicians without proper medical supervision.
- Legal Mandates: Rules require labs to be operated by qualified doctors and specialists to ensure accuracy and safety.
- State's Position: Maharashtra cites the Clinical Establishments Act, 2010, as the governing framework for lab regulation.
- Separate Governance: Hospitals are regulated separately under the Bombay Nursing Homes Act, creating potential coordination challenges.
- Court's Demand: The judiciary has asked for detailed data on inspections, violations, and penalties imposed.
- Public Health Impact: This issue raises serious concerns over patient safety and diagnostic standards across Maharashtra.
The Bombay High Court's intervention marks a crucial step toward addressing systemic flaws in the regulation of pathology laboratories. By demanding accountability and transparency from the Maharashtra government, the court aims to strengthen enforcement mechanisms and ultimately safeguard public health against the risks posed by unauthorized diagnostic facilities.
